Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma (Skin)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07426484
What this trial is testing

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Who this might be right for
Cutaneous Squamous Cell CarcinomaSkin Cancer
Dana-Farber Cancer Institute 80
Not applicableStudy completedNCT02580916
What this trial is testing

Utility of the Skin Cancer Quality of Life Impact Tool

Who this might be right for
Skin NeoplasmSquamous Cell CarcinomaBasal Cell Carcinoma
Oxford University Hospitals NHS Trust 318
Early research (Phase 1)Study completedNCT03219268
What this trial is testing

MGD013 in Patients With Unresectable or Metastatic Neoplasms

Who this might be right for
Advanced Solid TumorsHematologic NeoplasmsOvarian Cancer+7 more
MacroGenics 277
Not applicableLooking for participantsNCT06606028
What this trial is testing

Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of Head and NeckSquamous Cell Carcinoma Head and Neck Cancer (HNSCC)Squamous Cell Carcinoma of Skin+1 more
University of California, San Francisco 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT04349436
What this trial is testing

Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies

Who this might be right for
Merkel Cell CarcinomaBasal Cell CarcinomaLocally Advanced Cutaneous Squamous Cell Carcinoma+1 more
Replimune, Inc. 69
Not applicableStudy completedNCT00875381
What this trial is testing

Analysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin

Who this might be right for
Carcinoma, Basal CellCarcinoma, Squamous Cell
Mayo Clinic 100
Testing effectiveness (Phase 2)Looking for participantsNCT05877430
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer

Who this might be right for
NSCLCHNSCCMelanoma+3 more
CJ Bioscience, Inc. 160
Not applicableLooking for participantsNCT06384053
What this trial is testing

Skin Cancer and Hyperthermia and Radiotherapy

Who this might be right for
Basal Cell CarcinomaSquamous Cell Carcinoma SkinNon-melanoma Skin Cancer
Kantonsspital Winterthur KSW 100
Early research (Phase 1)Looking for participantsNCT04975152
What this trial is testing

Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

Who this might be right for
Merkel Cell CarcinomaCutaneous Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 36
Not applicableLooking for participantsNCT06615635
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

Who this might be right for
Squamous Cell CarcinomaAlpha RadiationImmunocompromised+3 more
Alpha Tau Medical LTD. 28
Testing effectiveness (Phase 2)Ended earlyNCT03737721
What this trial is testing

The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy

Who this might be right for
Squamous Cell Carcinoma of the Skin
AHS Cancer Control Alberta 8
Testing effectiveness (Phase 2)Study completedNCT00586040
What this trial is testing

Photochemical Tissue Bonding

Who this might be right for
Basal Cell CarcinomaSquamous Cell CarcinomaAtypical Nevus
Massachusetts General Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Not applicableUnknownNCT05886140
What this trial is testing

Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin

Who this might be right for
Squamous Cell Carcinoma of the Skin
Henan Cancer Hospital 24
Testing effectiveness (Phase 2)Study completedNCT00054691
What this trial is testing

ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin

Who this might be right for
Skin Cancer
M.D. Anderson Cancer Center 40
Very early researchStudy completedNCT04177498
What this trial is testing

Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Thomas Jefferson University 3
Testing effectiveness (Phase 2)Looking for participantsNCT07339176
What this trial is testing

Intratumoral N17350 in Advanced Solid Tumors

Who this might be right for
Neoplasms, Solid TumorBreast Neoplasms, Triple-NegativeSquamous Cell Carcinoma of Skin+4 more
Onchilles Pharma Inc 275
Early research (Phase 1)Ended earlyNCT02834247
What this trial is testing

TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors

Who this might be right for
Triple-Negative Breast NeoplasmsCarcinoma, Non-Small-Cell LungHead and Neck Carcinoma, Squamous Cell+1 more
Calithera Biosciences, Inc 41
Not applicableNot Yet RecruitingNCT06661577
What this trial is testing

An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.

Who this might be right for
Skin Cancers - Basal Cell CarcinomaSkin Cancers - Squamous Cell CarcinomaMelanoma of Skin+4 more
University of Auckland, New Zealand 3,000
Not applicableTemporarily pausedNCT02223975
What this trial is testing

Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease

Who this might be right for
Normal Vulval SkinLichen SclerosusHigh Grade Dysplasia - Usual Type ('VIN 2-3')+5 more
Gloucestershire Hospitals NHS Foundation Trust 200
Next Page